Wang Rong, Jin Chengmeng, Hu Xun
Cancer Institute, A Key Laboratory For Cancer Prevention & Intervention, Ministry of Education of the People's Republic of China, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Oncotarget. 2017 Jun 20;8(25):41113-41124. doi: 10.18632/oncotarget.17064.
One cancer cell line is believed to be composed of numerous clones with different drug sensitivity. We sought to investigate the difference of drug-response pattern in clones from a cell line or from a single cell. We showed that 22 clones derived from 4T1 cells were drastically different from each other with respect to drug-response pattern against 11 anticancer drugs and expression profile of 19 genes associated with drug resistance or sensitivity. Similar results were obtained using daughter clones derived from a single 4T1 cell. Each daughter clone showed distinct drug-response pattern and gene expression profile. Similar results were also obtained using Bcap37 cells. We conclude that a single cancer cell can rapidly produce a population of cells with high heterogeneity of drug response and the acquisition of drug-response heterogeneity is random.
一种癌细胞系被认为是由许多具有不同药物敏感性的克隆组成。我们试图研究来自同一细胞系或单个细胞的克隆在药物反应模式上的差异。我们发现,从4T1细胞衍生出的22个克隆在对11种抗癌药物的反应模式以及19个与耐药性或敏感性相关基因的表达谱方面彼此差异巨大。使用从单个4T1细胞衍生出的子克隆也获得了类似结果。每个子克隆都表现出独特的药物反应模式和基因表达谱。使用Bcap37细胞也得到了类似结果。我们得出结论,单个癌细胞能够迅速产生一群具有高度药物反应异质性的细胞,并且药物反应异质性的获得是随机的。